Identification of metallo- β -lactamase from a clinical isolate at Saint Camillle medical Center of Ouagadougou/ Burkina Faso.


Boukare ZEBA, Jacques SIMPORE, Odile G. NACOULMA ;
African Journal of Biotechnology Vol. 4 (3), pp. 286-288, ISSN 1684–5315 © 2005


http://www.ajol.info/index.php/ajb/article/view/15096/91002


INTRODUCTION
Bacteria escape the action of b-lactam antibiotics by producing hydrolytic enzymes, b-lactamases (Abraham and Chain, 1940). These enzymes are able to hydrolyse the b-lactam ring and give products which are harmless to bacteria. There are four classes of b-lactamases on the basis of molecular structure (Ambler, 1975, 1980, Ambler and Scott,1978) or functional characteristics (Bush,1988, 1989 a, b). Among them, metallo-blactamases (MBL) which belong to the molecular class B constitute a distinct family of b-lactamases (MBL).
Metallo-b-lactamases from most pathogenic bacteria are active with two Zn(II) ions bound to their active site (Ullah et al ., 1998 ;Wang et al, 1998). These enzymes are mainly reported in Asia and Europe. During our survey of b-lactamase incidence in bacterial resistance to b-lactam antibiotics we encountered a strain producing metallo-blactamase. To the best of our knowledge, this is the first time that the metallo-b-lactamase has been reported on the African continent. The aim of this simple communication is to inform the scientific community,
before undertaking further studies.


 


 



Code d’Ethique et de Déontologie des Enseignants-chercheurs du Burkina (...)

Appel à candidature pour inscription en Master 1 BIOGEMA 2015-2016

Copyright LaBioGene 2013 - 2014